A.S. ΕΜΠΟΡΙΚΗ-ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΙΑ Η/Υ & ΠΑΙΧΝΙΔΙΩΝ Α.Ε. financials
A.S. ΕΜΠΟΡΙΚΗ-ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΙΑ Η/Υ & ΠΑΙΧΝΙΔΙΩΝ Α.Ε.
213800NW1S2T9JRVU437 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €31.0M | €28.7M |
| Cost of sales | €15.9M | €14.8M |
| Gross profit | €15.1M | €13.9M |
| Other income | €122.1K | €78.0K |
| Distribution costs | €7.3M | €5.8M |
| Administrative expenses | €3.3M | €3.1M |
| Operating profit (EBIT) | €4.4M | €4.8M |
| Net finance income / (cost) | €1.2M | €1.1M |
| Profit before tax | €5.6M | €6.0M |
| Income tax expense | €1.4M | €1.4M |
| Profit for the year | €4.2M | €4.5M |
| — attributable to owners | €4.2M | €4.5M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | €4.2M | €4.5M |
| Per share | ||
| Basic EPS | €0.32 | €0.35 |
| Diluted EPS | €0.32 | €0.35 |
| Cash flow statement | ||
| Net cash from operating activities | €4.6M | -€763.8K |
| Income taxes paid | €1.4M | €919.7K |
| Net cash from investing activities | -€1.3M | -€1.7M |
| Net cash from financing activities | -€2.6M | -€1.6M |
| Dividends paid | €2.4M | €1.4M |
| Repayments of borrowings | €0 | €20.8K |
| Lease liability payments | €148.6K | €89.8K |
| Balance sheet | ||
| Total assets | €48.8M | €45.7M |
| Non-current assets | €9.9M | €9.3M |
| Property, plant & equipment | €3.9M | €4.3M |
| Right-of-use assets | €781.2K | €493.8K |
| Intangible assets & goodwill | €70.1K | €0 |
| Current assets | €38.9M | €36.4M |
| Inventories | €9.1M | €6.9M |
| Trade & other receivables | €13.3M | €14.6M |
| Cash & equivalents | €3.7M | €2.9M |
| Total equity | €39.3M | €37.7M |
| — attributable to owners | €39.3M | €37.7M |
| Non-current liabilities | €1.1M | €657.8K |
| Lease liabilities (non-current) | €650.3K | €413.8K |
| Current liabilities | €8.4M | €7.3M |
| Lease liabilities (current) | €161.6K | €93.9K |
| Deferred tax liabilities | €258.5K | €112.3K |
| Derived metrics | ||
| Operating margin | 14.2% | 16.8% |
| Net margin | 13.6% | 15.8% |
| Return on equity | 10.7% | 12.0% |
| Cash conversion ratio | 1.10× | -0.17× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€1.4M | €860.2K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€526.0K | -€7.0M |
| Adjustments For Depreciation and Amortisation Expense | €767.6K | €669.5K |
| Adjustments For Finance Income Cost | €1.2M | €1.1M |
| Adjustments For Increase Decrease In Trade and Other Payables | €3.0M | €1.0M |
| Adjustments For Provisions | €124.4K | -€4.1K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €8.2K | -€2.0K |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits and Investments | €6.5K | €6.4K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €1.5M | €0 |
| Current Financial Assets At Fair Value Through Profit Or Loss | €12.1M | €11.4M |
| Dividends Received Classified As Investing Activities | €0 | €0 |
| Equity and Liabilities | €48.8M | €45.7M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade Receivables | €0 | €56.4K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€2.9K | €389 |
| Increase Decrease In Cash and Cash Equivalents | €771.2K | -€4.1M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Transactions With Owners | -€2.6M | -€1.5M |
| Intangible Assets Other Than Goodwill | €912.5K | €506.0K |
| Interest Paid Classified As Operating Activities | €230.9K | €95.4K |
| Interest Received Classified As Investing Activities | €571.3K | €630.0K |
| Investment Property | €4.2M | €4.0M |
| Investments In Subsidiaries | €0 | €0 |
| Issued Capital | €8.7M | €8.7M |
| Liabilities | €9.5M | €8.0M |
| Noncurrent Provisions For Employee Benefits | €152.5K | €104.4K |
| Other Comprehensive Income | -€10.1K | -€2.8K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€13.0K | €1.8K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €71 | -€4.2K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€10.1K | €1.4K |
| Other Current Assets | €616.5K | €563.9K |
| Other Current Liabilities | €4.1M | €3.2M |
| Other Noncurrent Assets | €50.0K | €51.1K |
| Other Noncurrent Liabilities | €24.5K | €27.3K |
| Other Reserves | €2.2M | €2.1M |
| Payments To Acquire Or Redeem Entitys Shares | €89.4K | €0 |
| Purchase of Investment Property | €245.9K | €1.8M |
| Purchase of Treasury Shares | €89.4K | — |
| Research and Development Expense | €169.6K | €195.5K |
| Retained Earnings | €28.4M | €26.9M |
| Trade and Other Current Payables To Trade Suppliers | €4.1M | €4.0M |
Every line item above is a fact tagged in A.S. ΕΜΠΟΡΙΚΗ-ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΙΑ Η/Υ & ΠΑΙΧΝΙΔΙΩΝ Α.Ε.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.